In the context of cancer treatment, how are chimeric antigen receptor (CAR) T-cell therapies developed, and what
Fantastic news! We've Found the answer you've been seeking!
Question:
In the context of cancer treatment, how are chimeric antigen receptor (CAR) T-cell therapies developed, and what are the risks of off-target effects or cytokine release syndrome with these immunotherapies ?
Expert Answer:
Chimeric antigen receptor CAR Tcell therapy is a type of immunotherapy used in cancer treatment It involves genetically modifying a patients Tcells to ... View the full answer
Related Book For 
Posted Date:
